Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Eli Lilly developed tirzepatide based on the observation that GIP and GLP-1 produce complementary metabolic effects
Abstract Glucagon-like peptide 1 (GLP-1)-based therapies, such as semaglutide and tirzepatide, represent highly effective treatment options for people with type 2 diabetes and obesity, enabling effective control of glucose and weight loss, while reducing cardiovascular and renal morbidity and mortality
If a refill lapses beyond 45 days, the price steps up to $499 and higher, up to $1,049 per month
Live fully
Side effects Women facing persistent nausea, fatigue, or GI discomfort that with dose adjustments usually feel like trying a different medication
Volume 37
US$ 20.89
US$ 29.25
US$ 24.67
US$ 29.00
